As a result of the reduced ability of phagoctyes in CGD to clear infections, patients can suffer from troublesome, recurrent infections and inflammation. The projects we are funding are finding better ways of treating inflammation in CGD through understanding the way that normal cells clear infection and comparing it with cells carrying the mutations that cause CGD.
IMPORTANT NOTE :
The information contained on this website is intended only as a guideline, not as a substitute for medical advice. Always consult your doctor if you or your child has any CGD symptoms or concerns.
© 2001-2005 The Chronic Granulomatous Disorder (CGD)
Research Trust
Registered Charity No. 1003425 email:cgd@cgdrt.co.uk
The CGD Research Trust is a member of the Association of Medical Research Charities (AMRC), the Genetic Interest Group (GiG) and an associate member of the International Patient Organisation of Primary Immunodeficiencies (IPOPI)
Terms and Conditions | Privacy
